These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18822714)

  • 1. [The viewpoint of the medical oncologist].
    Benasso M
    Tumori; 2008; 94(4):suppl 26-9. PubMed ID: 18822714
    [No Abstract]   [Full Text] [Related]  

  • 2. [Docetaxel in the inductive therapy of head and neck cancer: recent evidence].
    Benasso M; Corvò R
    Tumori; 2008; 94(4):suppl 24-5. PubMed ID: 18822713
    [No Abstract]   [Full Text] [Related]  

  • 3. [ASCO 2006 Gastrointestinal Cancers Symposium, San Francisco, 26-28 January 2006].
    Tumori; 2006; 92(2):1-20. PubMed ID: 16724704
    [No Abstract]   [Full Text] [Related]  

  • 4. Larynx preservation and survival trends: should there be concern?
    Forastiere AA
    Head Neck; 2010 Jan; 32(1):14-7. PubMed ID: 19953631
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combination radio and chemotherapy from the viewpoint of the medical oncologist].
    Engelhardt R
    Strahlentherapie Sonderb; 1978; 75():88-95. PubMed ID: 555059
    [No Abstract]   [Full Text] [Related]  

  • 6. [The viewpoint of the radiotherapy oncologist].
    Corvò R
    Tumori; 2008; 94(4):suppl 30-3. PubMed ID: 18822715
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metastatic breast cancer: is global survival increase a realistic endpoint in phase III clinical trials? Studies on taxanes; studies on trastuzumab. What repercussions will they have in clinical practice?].
    Colozza M
    Suppl Tumori; 2004; 3(4):S67-9. PubMed ID: 15206217
    [No Abstract]   [Full Text] [Related]  

  • 8. When an interim analysis of randomized trial changes the practice in oncology: the lesson of adjuvant Trastuzumab and the HERA trial.
    De Rossi C; Brunello A; Jirillo G; Jirillo A
    Immunopharmacol Immunotoxicol; 2009 Mar; 31(1):30-1. PubMed ID: 21054206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant docetaxel-based treatment for breast cancer.
    Tilstone C
    Lancet Oncol; 2007 Jan; 8(1):15. PubMed ID: 17348121
    [No Abstract]   [Full Text] [Related]  

  • 10. Unravelling the mystery of the TACT trial.
    Martin M
    Lancet; 2009 May; 373(9676):1662-3. PubMed ID: 19447241
    [No Abstract]   [Full Text] [Related]  

  • 11. Anaplastic thyroid carcinoma with long term survival after combined treatment: case report.
    Kurukahvecioglu O; Ege B; Poyraz A; Tezel E; Taneri F
    Endocr Regul; 2007 Mar; 41(1):41-4. PubMed ID: 17437344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
    Dunst J; Haensgen G
    Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined chemotherapy and radiation for locally advanced cervical carcinoma.
    Bridgewater J
    Clin Oncol (R Coll Radiol); 1998; 10(2):78-83. PubMed ID: 9610895
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metastatic breast cancer: is global survival increase a realistic endpoint in phase III clinical trials? Studies on taxanes; studies on trastuzumab].
    Bria E; Vanni B; Cuppone F; Calabretta F; Campanella C; Torsello A; Terzoli E
    Suppl Tumori; 2004; 3(4):S65-6. PubMed ID: 15206216
    [No Abstract]   [Full Text] [Related]  

  • 15. Is it time to abandon complete blinded independent central radiological evaluation of progression in registration trials?
    Pignatti F; Hemmings R; Jonsson B
    Eur J Cancer; 2011 Aug; 47(12):1759-62. PubMed ID: 21641204
    [No Abstract]   [Full Text] [Related]  

  • 16. Is the easier way ever the better way?
    Chi DS; Bristow RE; Armstrong DK; Karlan BY
    J Clin Oncol; 2011 Nov; 29(31):4073-5. PubMed ID: 21931018
    [No Abstract]   [Full Text] [Related]  

  • 17. Relapse pattern of GOG 122 trial should be more informative.
    Ozyar E; Genc M
    J Clin Oncol; 2006 Aug; 24(22):3709-10; author reply 3710. PubMed ID: 16877741
    [No Abstract]   [Full Text] [Related]  

  • 18. Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?
    Hall RR
    Acta Urol Belg; 1996 May; 64(2):39-42. PubMed ID: 8701809
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lung cancer: 25-year experience with surgical and combined treatment].
    Dobrodeev AIu; Zav'ialov AA; Tuzikov SA; Miller SV
    Vopr Onkol; 2010; 56(2):201-5. PubMed ID: 20552898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to M. Mohiuddin et al.
    Dewdney A; Hawkes EA; Cunningham D
    J Clin Oncol; 2011 Jul; 29(19):2737-8. PubMed ID: 21850737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.